Sitemap
June 03, 2018 Articles
Filter by Available Specialty
- Benefit of first-line alectinib persists over crizotinib for ALK-positive lung cancer
- Cytoreductive nephrectomy no longer the standard for metastatic renal cell carcinoma
- Disease duration predicts response to GPOEM for gastroparesis
- Early patient status predicts long-term outcomes of biologic treatment for Crohn’s disease
- Exclusion from HBV therapy by AASLD criteria often leads to adverse outcomes
- Gene test identifies women with early breast cancer who can be spared adjuvant chemotherapy
- Germline variant alleles may predict response to first-line abiraterone for metastatic prostate cancer
- HCV outcomes worse for patients with public insurance, Medicaid
- Hormone therapy linked to microscopic colitis risk in postmenopausal women
- IBS-C linked to pelvic floor symptoms
- IL-15 inhibitor among key celiac research at DDW 2018
- JTX-2011 shows activity for gastric, triple-negative breast cancers
- Long-term treatment-free remission achievable for chronic myeloid leukemia
- Maintenance chemotherapy improves OS in rhabdomyosarcoma
- Metabolomics profile identifies coronary artery disease risk in NAFLD
- Microbiome therapy induces remission in mild-to-moderate UC
- New study confirms efficacy of permethrin-treated clothing against tick bites
- Novel nivolumab combination shows efficacy for advanced solid tumors
- Once-weekly carfilzomib effective for relapsed, refractory myeloma
- Osteoporosis associated with risk for sudden hearing loss
- Taselisib with fulvestrant modestly improves PFS in PIK3CA-mutated breast cancer
- Transparent cap improves single balloon enteroscopy for examining GI bleeds
- VIDEO: New insights on AF burden as a measure of stroke risk
- VIDEO: Panel recommends NSAIDs in cataract surgery in CME
- VIDEO: Provance speaks about concussions in adventure athletes